Overview
Maarit Lappalainen practices practicing medicine in Helsinki, Finland.
Their clinical expertise encompasses Hemorrhagic Proctocolitis, Ulcerative Colitis, and Colitis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maarit Lappalainen
Is Maarit Lappalainen a top-rated expert for Hemorrhagic Proctocolitis?
MediFind is an objective health platform that identifies experts based on real-world data. Maarit Lappalainen is classified as an Experienced expert for Hemorrhagic Proctocolitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maarit Lappalainen participate in research or clinical trials?
Yes. Maarit Lappalainen has published 8 articles and abstracts on conditions like Hemorrhagic Proctocolitis. You can view a list of Maarit Lappalainen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ColitisLappalainen isExperienced. Learn about Colitis.
- Hemorrhagic ProctocolitisLappalainen isExperienced. Learn about Hemorrhagic Proctocolitis.
- Ulcerative ColitisLappalainen isExperienced. Learn about Ulcerative Colitis.